Ultimately, KU60019 contributes to tumor cell killing by blocking the HADCi mediated p21 transcriptional induction facilitating the G2 to M transition while romidepsin induce aberrant mitosis and premature mitotic exit (Figure 6C). The gene discussed is CDKN1A; the disease is neoplasm.